ICLR Stock Analysis: Buy, Sell, or Hold?
ICLR - Icon Plc
$166.10
-1.62 (-0.97%)
▼
5d:
-2.83%
30d:
+14.88%
90d:
+55.51%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 22, 2026
7d
Smart Money Distribution
None View Scanner →
Strength: 6.6/10
Get Alerted When ICLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ICLR shows positive signals but monitor for confirmation. Market pricing in 7.9% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ICLR shows positive signals but monitor for confirmation. Market pricing in 7.9% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$190.83
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$118.49
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICLR is currently trading at $166.10, which is considered slightly high relative to its 30-day fair value range of $146.16 to $169.42. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.0) compared to its historical average (11.1). At these levels, the market is pricing in 7.9% annual earnings growth.
Technical Outlook: Technically, ICLR is in a downtrend. The price is approaching resistance at $156.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICLR is in a downtrend. The price is approaching resistance at $156.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$146.16 -
$169.42
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.8%
All Signals
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($180.81)
- BULLISH: Expecting earnings turnaround to 7.9% growth with 0.9% revenue growth
Trading Range Analysis
30-Day Trading Range
$146.16 -
$169.42
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$11.84
(7.1%)
Support & Resistance Levels
Support Level
$113.94
Resistance Level
$156.20
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.01
Wall Street Target
$180.81
(+8.9%)
Revenue Growth (YoY)
0.9%
Earnings Growth (YoY)
-31.7%
Profit Margin
2.1%
Valuation Premium vs History
+7.9% premium
PE vs Historical
14.0 vs 11.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.9%
(market-implied from PE analysis)
1-Year Target
$179.22
(+8%)
2-Year Target
$193.38
(+16%)
3-Year Target
$208.66
(+26%)
3-Yr Target (if PE normalizes)
(PE: 14→11)
PE COMPRESSION
$165.30
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.5%)
$357.79
(+115%)
Base:
(SPY PE: 14.0, Growth: 11.5%)
$230.17
(+39%)
Bear:
(PE: 11.1, Growth: 11.5%)
$182.34
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Forward PE: 16.05 | Forward EPS (Implied): $10.35
Bull Case
$200.57
(+21%)
Analyst growth 15.0%, PE expands to 16.9
Base Case
$166.10
(0%)
Market implied 0.0%, PE stable at 16.1
Bear Case
$127.07
(-24%)
Severe decline -15.0%, PE contracts to 14.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 11:31 PM ET
Data refreshes hourly during market hours. Next update: 12:31 AM
Data refreshes hourly during market hours. Next update: 12:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 67 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$157 | 60 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 54 HOLD |
Advanced ICLR Option Strategies
Professional options setups generated by AI based on today's ICLR price and gamma walls.
